Visceral Leishmaniasis with Hemophagocytic Syndrome in a patient infected by SARS-COV2: a case report
Introduction: Visceral leishmaniasis is a disease that determines a picture of immunosuppression in the patient after contact with infected sandflies. Secondary hemophagocytic syndrome, on the other hand, is an immune-mediated condition that develops after infections, neoplasms, or autoimmune diseas...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | Brasil |
| Institución: | Faculdade de Medicina do ABC (FMABC) |
| Repositorio: | ABCS Health Sciences (Online) |
| Idioma: | inglés |
| OAI Identifier: | oai:ojs.emnuvens.com.br:article/2412 |
| Acceso en línea: | https://www.portalnepas.org.br/abcshs/article/view/2412 |
| Access Level: | acceso abierto |
| Palabra clave: | Leishmaniasis, Visceral Syndrome COVID-19 Lymphohistiocytosis hemophagocytic SARS-CoV-2 coinfection Leishmaniose visceral Linfo-histiocitose hemofagocítica coinfecção |
| Sumario: | Introduction: Visceral leishmaniasis is a disease that determines a picture of immunosuppression in the patient after contact with infected sandflies. Secondary hemophagocytic syndrome, on the other hand, is an immune-mediated condition that develops after infections, neoplasms, or autoimmune diseases. COVID-19 has infected more than 130 million people and caused more than 2.6 million deaths worldwide. Immunosuppression triggered by COVID-19 can be an aggravating factor for latent infections. Report: This article reported the case of a patient, 37 years old, with a previous history of Severe Acute Respiratory Distress Syndrome due to SARS-COV-2, later diagnosed with Hemophagocytic Syndrome Secondary to Visceral Leishmaniasis. Conclusion: A SARS-CoV-2 pandemic has revealed cases of co-infection with visceral leishmaniasis, highlighting the need for case reports that contribute to the efficiency of diagnosing and treating patients with comorbidities, aiming for a favorable outcome in the clinical condition of the patients. |
|---|